135 related articles for article (PubMed ID: 15272583)
41. [Three successful case reports of advanced gastric cancer with chemotherapy].
Yamamoto M; Niinobu T; Taniguchi H; Kotobuki T; Fukunaga K; Kawai M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1689-92. PubMed ID: 15553684
[TBL] [Abstract][Full Text] [Related]
42. [A case of advanced gastric cancer with peritoneal dissemination effectively treated by combined chemotherapy of paclitaxel (TXL) and TS-1].
Kuriyama H; Nonaka T; Sawatari T; Tsuboi H; Akanuma M; Hata Y
Gan To Kagaku Ryoho; 2005 May; 32(5):663-5. PubMed ID: 15918568
[TBL] [Abstract][Full Text] [Related]
43. [Weekly administration of paclitaxel with a short course of premedication for advanced or recurrent gastric cancer].
Yamamoto S; Tanaka Y; Ito T; Nakai S; Morimoto Y; Kitagawa T; Kurihara Y; Nishimura J
Gan To Kagaku Ryoho; 2003 Jan; 30(1):67-71. PubMed ID: 12557707
[TBL] [Abstract][Full Text] [Related]
44. [A resected case of stage IV gastric cancer successfully treated with TS-1/CDDP as neoadjuvant chemotherapy].
Oshiro Y; Moon Y; Yamamoto Y; Aita K
Gan To Kagaku Ryoho; 2006 May; 33(5):667-70. PubMed ID: 16685169
[TBL] [Abstract][Full Text] [Related]
45. A phase I study of S-1 administration and a 24-h infusion of cisplatin plus paclitaxel in patients with advanced gastric cancer.
Iwase H; Shimada M; Tsuzuki T; Okeya M; Kobayashi K; Hibino Y; Watanabe H; Goto H
Anticancer Res; 2006; 26(2B):1605-9. PubMed ID: 16619579
[TBL] [Abstract][Full Text] [Related]
46. [Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer].
Makari Y; Fujiwara Y; Yasuda T; Takiguchi S; Kimura Y; Yano M; Monden M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):609-11. PubMed ID: 15114710
[TBL] [Abstract][Full Text] [Related]
47. [A case of gastric cancer with peritoneal dissemination who achieved five-year survival by successive treatments with TS-1 alone and in combination with other drugs].
Aiko S; Yoshizumi Y; Sugiura Y; Ishizuka T; Sakano T; Kumano I; Maehara T
Gan To Kagaku Ryoho; 2006 Feb; 33(2):239-42. PubMed ID: 16484864
[TBL] [Abstract][Full Text] [Related]
48. A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer.
Hokita S; Aikou T; Miyazono F; Ishigami S; Aridome K; Maenohara S; Saihara T; Suenaga K; Nomura H; Maeda S; Takatori H; Arima H; Uchikado Y; Natsugoe S; Takao S
Cancer Chemother Pharmacol; 2006 Jun; 57(6):736-40. PubMed ID: 16163539
[TBL] [Abstract][Full Text] [Related]
49. [Combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer].
Hokita S; Aikou T; Ishigami S; Miyazono F; Nakajo A; Uenosono Y; Hamanoue M; Aridome K; Natsugoe S
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():95-8. PubMed ID: 16897981
[TBL] [Abstract][Full Text] [Related]
50. [A case responding to weekly paclitaxel therapy as second-line chemotherapy for gastric cancer previously treated with TS-1].
Imamura H; Furukawa H; Kishi K; Tatsuta M; Masutani S; Fukunaga M; Nakayama T; Shimizu J; Takemoto H; Kishimoto T; Kato H; Yamamoto K; Fujishima M; Kawasaki T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1693-5. PubMed ID: 15553685
[TBL] [Abstract][Full Text] [Related]
51. [Three advanced gastric cancer cases with liver metastases successfully treated by TS-1/CDDP combination therapy].
Ina K; Kataoka T; Nagao S; Ito A; Ito N; Matsui W; Inagaki J; Goto H
Gan To Kagaku Ryoho; 2006 Jan; 33(1):95-8. PubMed ID: 16410706
[TBL] [Abstract][Full Text] [Related]
52. [A new regimen for TS-1 therapy designed to minimize adverse reactions by introducing a one-week interval after each two-week dosing session].
Kimura Y; Kikkawa N; Iijima S; Kato T; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1403-9. PubMed ID: 12214468
[TBL] [Abstract][Full Text] [Related]
53. A phase II multicentric trial of S-1 combined with 24 h-infusion of cisplatin in patients with advanced gastric cancer.
Iwase H; Shimada M; Tsuzuki T; Horiuchi Y; Kumada S; Haruta J; Yamaguchi T; Sugihara M; Ina K; Kusugami K; Goto S
Anticancer Res; 2005; 25(2B):1297-301. PubMed ID: 15865081
[TBL] [Abstract][Full Text] [Related]
54. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.
Inada S; Tomidokoro T; Fukunari H; Sato T; Hatano T; Nishimura A; Kawauchi Y; Nikkuni K; Shimizu T; Sato T; Yanagi M; Takahashi S; Yoshida H; Sugita M; Hayashi T
Cancer Chemother Pharmacol; 2009 Jan; 63(2):267-73. PubMed ID: 18379784
[TBL] [Abstract][Full Text] [Related]
55. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
[TBL] [Abstract][Full Text] [Related]
56. [Efficacy of S-1 combined with weekly Paclitaxel for gastric cancer with cancerous ascites].
Hara A; Tsunemi S; Yamamoto M; Izumi N; Iwamoto S
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1815-8. PubMed ID: 18030015
[TBL] [Abstract][Full Text] [Related]
57. [A case of stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy].
Jingu K; Sasagawa K; Kagaya A; Ochiai T
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2117-20. PubMed ID: 16352940
[TBL] [Abstract][Full Text] [Related]
58. [Neoadjuvant chemotherapy using TS-1 and CDDP against large type 3/Type 4/Bulky N 2 advanced gastric cancer].
Tanemura H; Oshita H; Kanno A; Kusakabe M; Hatoh T; Yamada M; Adachi T; Nishio K; Saito S; Tomita E; Sugiyama A; Yamada T
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2079-85. PubMed ID: 16352932
[TBL] [Abstract][Full Text] [Related]
59. [A patient with gastric cancer complicated with severe DIC and multiple bone metastasis showing a high response to combination of TS-1 and CDDP].
Yoshioka S; Tsujinaka T; Kida H; Hirao M; Fujitani K
Gan To Kagaku Ryoho; 2003 Mar; 30(3):403-6. PubMed ID: 12669401
[TBL] [Abstract][Full Text] [Related]
60. [Two cases of advanced and recurrent gastric cancer treated with the combination of chemotherapy and radiation].
Fujiwara Y; Miyata H; Takiguchi S; Yasuda T; Yano M; Monden M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1876-8. PubMed ID: 15553745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
